Mayne Pharma Group (MYX)- BUY
MYX’s FY18 result came in ahead of market expectations at the earnings line, with the Company enjoying a
Analyst Research
Analyst Research
Costa Group Holdings (CGC) – NEUTRAL
Costa Group Holdings (CGC) FY18 result missed analyst estimates with NPAT before SGARA and excluding material items of
Analyst Research
Newcrest Mining (NCM) – NEUTRAL
Newcrest Mining (NCM) posted full year (FY18) results which were impacted by lower production volumes in gold (-1%)
Analyst Research
G8 Education Ltd (GEM) – BUY
GEM’s first half calendar 2018 (1H18) highlighted that the current oversupply in the industry is not abating and
Analyst Research
IRESS Ltd (IRE) – NEUTRAL
IRESS Ltd (IRE) is an ASX-listed company that specialise in software for the finance industry, with a focus
Analyst Research
Northern Star Resources (NST) – Neutral
NST reported record FY18 results after a slightly disappointing half year, with key figures: 1. NPAT up +3%
Analyst Research
Qantas Group Ltd (QAN) – BUY
Qantas Group (QAN) posted record profit levels with growth in all segments contributing to underlying profit of $1.6bn
Analyst Research
Tassal Group (TGR) – BUY
TGR’s FY18 operating profit of $50.3m and operating EBITDA of $99.78m came in below consensus estimates of $51.2m
Analyst Research
Platinum Asset Mgmt (PTM) – NEUTRAL
Platinum Asset Management (PTM) saw its share price increase marginally after the Company’s FY18 results.
Analyst Research
Santos Ltd (STO) – Neutral
Santos (STO) delivered a solid first half 2018 (1H18) results, with the company declaring its first dividend since